Peter Mac News

General News

Monash University and Peter Mac forge closer ties

2 min read 07 June 2023

Monash University and the Peter MacCallum Cancer Centre will drive forward world-class cancer research while training the next generation of clinicians and scientists, with a new partnership agreement now in place.

 Untitled design2

As Australia’s leading Comprehensive Cancer Centre focused on cancer care, research and education, Peter Mac will collaborate more closely with Monash University across all forms of research – in laboratories, clinics and for health services research initiatives.

The partnership will also enable more Monash University undergraduate, honours and post-graduate students to access research and clinical placements, as well as other supervised education opportunities at Peter Mac. The renewed and refreshed Affiliation Agreement was officially signed on Wednesday 7 June, building on a previous agreement that has been in place since 2017.

The agreement recognises the strengths of Monash University, which is ranked in the world’s top 50 universities in the 2023 Times Higher Education World University Rankings, while acknowledging Peter Mac’s unique role as Australia’s only public health services dedicated to caring for people with cancer.

 DSC06051

Peter Mac Chief Executive Professor Shelley Dolan said the Affiliation Agreement was a significant step that would accelerate the achievements of these two leading organisations.

“We are delighted to embark on this expanded partnership with Monash University, which reflects the strong collaborations that our people have shared for many years,” Professor Dolan says.

“Working together helps both organisations to progress our shared goals of advancing cancer treatment and research, and of building a bigger and more equipped healthcare workforce in Victoria.”

Monash University Executive Dean, Faculty of Medicine, Nursing and Health Sciences Professor Christina Mitchell AO said: “Innovative, new ideas that have the greatest potential to advance cancer research and improve clinical outcomes are possible when the brightest minds in basic lab-based research work closely with talented clinicians.”

“This collaboration has the potential to accelerate the pace of cancer research by bringing teams together from two great institutions.”

The Affiliation Agreement, which is in place for at least five years, prioritises areas of mutual leadership to enable breakthroughs on future treatment and models of patient care, while ensuring Victoria and Australia more broadly, is home to a strengthened, future-ready health system.